Patent Settlements for Generic Drugs
Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The Su…
test
Witnesses testified on drug company “pay-for-delay” deals, a ploy by to keep generic alternatives off the market. The Su…
Chief executive officers (CEOs) of several pharmaceutical companies and two Food and Drug Administration (FDA) officials…
The topic of opioid addiction was on the agenda of the nation’s governors at their annual winter meeting in Washington, …
Senators Jeanne Shaheen (D-NH), Kelly Ayotte (R-NH) and Rob Portman (R-OH), Governor Peter Shumlin (D-VT), federal drug …